Brochure | October 10, 2022

Transform Clinical Trials With Cognizant SIP: Efficient, Collaborative, Virtual

Source: Cognizant
What The New FDA Guidance On Electronic Records And Signatures Means For Clinical Trials

Cognizant Shared Investigator Platform (SIP) provides a single point of access for multiple clinical trial resources across sponsors and investigation sites. This collaborative platform enables investigators and site staff to work together with sponsors in one central workspace, so the management of studies is more efficient, and information is easily shared–even as trials become increasingly decentralized and sites, patients and sponsors must collaborate remotely.

Cognizant SIP helps reduce many of the redundant tasks associated with site selection and qualification. By tracking study startup tasks and routing key communications, such as notices of study changes and safety notifications, the system allows investigators and their staff to spend more time with their patients, doing the work that matters most.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Tech Leader? Subscribe today.

Subscribe to Clinical Tech Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Tech Leader